S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
NASDAQ:PGNY

Progyny - PGNY Stock Forecast, Price & News

$37.08
+1.87 (+5.31%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$35.49
$37.13
50-Day Range
$28.16
$37.08
52-Week Range
$25.67
$53.10
Volume
1.47 million shs
Average Volume
736,840 shs
Market Capitalization
$3.44 billion
P/E Ratio
88.29
Dividend Yield
N/A
Price Target
$49.25

Progyny MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
32.8% Upside
$49.25 Price Target
Short Interest
Healthy
9.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.53mentions of Progyny in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$2.19 M Sold Last Quarter
Proj. Earnings Growth
27.59%
From $0.29 to $0.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.86 out of 5 stars

Medical Sector

41st out of 1,030 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

1st out of 9 stocks

PGNY stock logo

About Progyny (NASDAQ:PGNY) Stock

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Receive PGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Progyny and its competitors with MarketBeat's FREE daily newsletter.

PGNY Stock News Headlines

What Does Amazon's Acquisition of 1LifeMedical Mean To Investors? (PGNY)
After the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors?
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Should You Retain Progyny (PGNY) Stock?
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Does Progyny (PGNY) Have High Growth Prospects?
Progyny Third Quarter 2022 Earnings: Beats Expectations
Progyny, Inc. Announces Third Quarter 2022 Results
Progyny (PGNY) Q3 Earnings and Revenues Top Estimates
Is Progyny (PGNY) a Rapidly Growing Business?
See More Headlines
Receive PGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Progyny and its competitors with MarketBeat's FREE daily newsletter.

PGNY Company Calendar

Last Earnings
11/04/2021
Today
2/02/2023
Next Earnings (Estimated)
2/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PGNY
Fax
N/A
Employees
311
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$49.25
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$34.00
Forecasted Upside/Downside
+32.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$65.77 million
Pretax Margin
2.84%

Debt

Sales & Book Value

Annual Sales
$500.62 million
Cash Flow
$0.80 per share
Book Value
$2.78 per share

Miscellaneous

Free Float
79,879,000
Market Cap
$3.44 billion
Optionable
Not Optionable
Beta
1.59

Key Executives

  • Mr. David J. SchlangerMr. David J. Schlanger (Age 64)
    Exec. Chairman
    Comp: $862.46k
  • Mr. Peter Anevski (Age 56)
    CEO & Director
    Comp: $785.77k
  • Mr. Mark S. Livingston (Age 57)
    Chief Financial Officer
    Comp: $955.47k
  • Mr. Michael Sturmer (Age 46)
    Pres
  • Mr. James Hart
    VP of Investor Relations
  • Allison Swartz
    Exec. VP & Gen. Counsel
  • Ms. Risa Fisher
    Exec. VP & Chief Marketing Officer
  • Ms. Cassandra Pratt
    Sr. VP of People
  • Ms. Julie Stadlbauer
    Exec. VP of Strategic Sales & Partnerships
  • Ms. Arielle Bogorad
    Sr. VP of Employer Market Strategy













PGNY Stock - Frequently Asked Questions

Should I buy or sell Progyny stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Progyny in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PGNY shares.
View PGNY analyst ratings
or view top-rated stocks.

What is Progyny's stock price forecast for 2023?

4 analysts have issued twelve-month price targets for Progyny's stock. Their PGNY share price forecasts range from $34.00 to $62.00. On average, they predict the company's stock price to reach $49.25 in the next year. This suggests a possible upside of 35.7% from the stock's current price.
View analysts price targets for PGNY
or view top-rated stocks among Wall Street analysts.

How have PGNY shares performed in 2023?

Progyny's stock was trading at $31.15 at the beginning of the year. Since then, PGNY shares have increased by 16.5% and is now trading at $36.30.
View the best growth stocks for 2023 here
.

When is Progyny's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our PGNY earnings forecast
.

How were Progyny's earnings last quarter?

Progyny, Inc. (NASDAQ:PGNY) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.17 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.11. The firm had revenue of $122.30 million for the quarter, compared to analysts' expectations of $125.52 million. Progyny had a trailing twelve-month return on equity of 14.14% and a net margin of 6.00%. Progyny's quarterly revenue was up 23.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.05 earnings per share.

What guidance has Progyny issued on next quarter's earnings?

Progyny updated its fourth quarter 2022 earnings guidance on Sunday, January, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $213.91 million-$213.91 million, compared to the consensus revenue estimate of $210.64 million.

What is David Schlanger's approval rating as Progyny's CEO?

25 employees have rated Progyny Chief Executive Officer David Schlanger on Glassdoor.com. David Schlanger has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Progyny own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Progyny investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Marvell Technology (MRVL), Alteryx (AYX), Micron Technology (MU), AbbVie (ABBV), Home Depot (HD), Advanced Micro Devices (AMD).

When did Progyny IPO?

(PGNY) raised $150 million in an IPO on Friday, October 25th 2019. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch acted as the underwriters for the IPO and Citigroup, Piper Jaffray, SVB Leerink and TPG Capital were co-managers.

What is Progyny's stock symbol?

Progyny trades on the NASDAQ under the ticker symbol "PGNY."

Who are Progyny's major shareholders?

Progyny's stock is owned by many different retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (1.75%), Riverbridge Partners LLC (1.52%), Crestwood Capital Management L.P. (0.61%), Congress Asset Management Co. MA (0.44%), Fort Washington Investment Advisors Inc. OH (0.40%) and International Assets Investment Management LLC (0.18%). Insiders that own company stock include Beth C Seidenberg, Cheryl Scott, David J Schlanger, David J Schlanger, Group Holdings (Sbs) Advis Tpg, Jennifer Bealer, Lisa Greenbaum, Mark S Livingston, Norman Payson, Perkins Caufield & Bye Kleiner, Peter Anevski, Plc Glaxosmithkline and Robert Michael Floyd.
View institutional ownership trends
.

How do I buy shares of Progyny?

Shares of PGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Progyny's stock price today?

One share of PGNY stock can currently be purchased for approximately $36.30.

How much money does Progyny make?

Progyny (NASDAQ:PGNY) has a market capitalization of $3.37 billion and generates $500.62 million in revenue each year. The company earns $65.77 million in net income (profit) each year or $0.42 on an earnings per share basis.

How many employees does Progyny have?

The company employs 311 workers across the globe.

How can I contact Progyny?

Progyny's mailing address is 1359 BROADWAY, NEW YORK NY, 10018. The official website for the company is www.progyny.com. The company can be reached via phone at 212-888-3124 or via email at investors@progyny.com.

This page (NASDAQ:PGNY) was last updated on 2/3/2023 by MarketBeat.com Staff